Showing results (1-10 of 13) with videos related to
Sort By:
Pageof 2
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|February 6, 2026
Definitive cefepime versus carbapenems for bacteremia caused by Enterobacterales with a risk of chromosomal AmpC production in childrenTakashi Shoji, Yuto Otsubo, Yuho HorikoshiBMJ Case Reports|April 8, 2021
Type 3 antenatal Bartter syndrome presenting with mild polyuriaYuto Otsubo, Yuji Kano, Hiroshi Suzumura, et al.The Pediatric Infectious Disease Journal|March 7, 2024
Joint Fluid Cell Count in Acute Bacterial Arthritis Patients Proven Positive Culture in ChildrenYuto Otsubo, Meiwa Shibata, Hiroshi Hataya, et al.The Pediatric Infectious Disease Journal|July 16, 2026
Definitive Cefmetazole Therapy for Pediatric ESBL-producing Enterobacterales BacteremiaYuto Otsubo, Yo Murata, Kazue Kinoshita, et al.Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|December 18, 2025
The first pediatric case successfully treated with cefiderocol for IMP-type carbapenemase-producing Enterobacterales bacteremiaHaruna Mori, Yuto Otsubo, Meiwa Shibata, et al.Journal of Perinatology : Official Journal of the California Perinatal Association|March 4, 2025
Extended-spectrum β-lactamase-producing Enterobacterales infections among infants following vertical colonization in a neonatal intensive care unitMimori Abe, Yuto Otsubo, Tomoyuki Tame, et al.Pediatric Dermatology|August 6, 2026
DTaP-IPV Vaccination-Induced Granuloma Diagnosed With Multi-Virus/Microbial Real-Time PCRHiroshi Hayashi, Yuto Otsubo, Kentaro Matsuoka, et al.Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|August 30, 2024
Chronic amoxicillin shortage led to alternative broad-spectrum antimicrobial use in pediatric clinicsYuto Otsubo, Nobuaki Matsunaga, Ai Tsukada, et al.Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|January 25, 2025
Letermovir-inclusive combination therapy for a refractory and resistant infection by cytomegalovirus with UL54 mutation following a hematopoietic stem cell transplant for MHC class II deficiencyNoor Diana Ashaari Muhamad, Nobuhiro Kanie, Yuto Otsubo, et al.Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|December 6, 2025
Limitations of the AWaRe antibiotic classification during the 2024 Mycoplasma pneumoniae epidemic in TokyoYuto Otsubo, Rentaro Oda, Yo Murata, et al.Pageof 2